What is the story behind the development of the new coronavirus vaccine?

The outbreak of the epidemic in the first half of 2020 affected the hearts of people across the country, and now China has greatly improved its control of the epidemic. The international epidemic situation is getting more and more serious. The development process of the new coronavirus vaccine has always been the focus of people around the world. Finally, good news came from China on July 22. Zheng Zhongwei, director of the Science and Technology Development Center of the National Health Commission, said in an interview that China has officially launched the emergency use of the new crown vaccine on July 22.

So far, according to the latest data released by the world's authoritative health organization, the cumulative number of confirmed cases of new coronary pneumonia in the world has reached 23,963,653, including 8,485,171 deaths. In the process of fighting the virus, the inactivated vaccine for COVID-19 has always been considered by everyone to be a very important weapon.

In accordance with the decisions and arrangements of the Party Central Committee, the scientific research team under the leadership of the Central Leading Group for Epidemic Response and the Joint Prevention and Control Mechanism of the State Council began to lay out the vaccine research and development tasks. Finally, on February 15, the scientific research team A special class for vaccine research and development has been set up. The vaccine research and development special class is for front-line scientific research and provides full-chain, point-to-point services. They quickly assembled the most advantageous scientific and technological forces in the country. At the same time, they sorted out the protective materials, experimental animals, and various experimental resources that needed to be urgently deployed, and identified the most important time points for each project.

It is clearly stipulated in the "Vaccine Management Law" that when a particularly major public health event occurs in the country, an application for emergency use of a vaccine submitted by the National Health Commission must be approved by the National Food and Drug Administration. Experts from the bureau organized arguments and agreed. The main purpose is to establish an immune barrier among basic personnel such as medical personnel who ensure the operation of the city, so as to ensure the stable operation of the entire country.

The good news coming from China has undoubtedly given most people reassurance. China is also contributing its wisdom and strength to the world.